{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:03:43Z","timestamp":1791979423866,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s11695-022-06379-0","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T12:14:38Z","timestamp":1670847278000},"page":"585-599","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The Effectiveness and Safety of the Duodenal-Jejunal Bypass Liner (DJBL) for the Management of Obesity and Glycaemic Control: a Systematic Review and Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.1007","volume":"33","author":[{"given":"Erika Yuki","family":"Yvamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo Turiani Hourneaux","family":"de Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor Mendon\u00e7a","family":"Proen\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Epifanio Silvino","family":"do Monte Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1844-8973","authenticated-orcid":false,"given":"Igor Braga","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Henrique Boraschi Vieira","family":"Ribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matheus C\u00e2ndido","family":"Hemerly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Lira","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio A.","family":"S\u00e1nchez-Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanderley Marques","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Guimar\u00e3es Hourneaux","family":"de Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"6379_CR1","unstructured":"World Obesity Federation. Prevalence of obesity [Internet]. [cited 2022 Mar 12]. Available from: https:\/\/www.worldobesity.org\/about\/about-obesity\/prevalence-of-obesity"},{"key":"6379_CR2","unstructured":"McKinsey Global Institute. Overcoming obesity: an initial economic analysis [Internet]. 2014. [cited 2022 Mar 12]. Available from: https:\/\/www.mckinsey.com\/~\/media\/mckinsey\/business functions\/economic studies temp\/our insights\/how the world could better fight obesity\/mgi_overcoming_obesity_full_report.ashx"},{"key":"6379_CR3","doi-asserted-by":"crossref","unstructured":"Na HK, De Moura DTH. Various novel and emerging technologies in endoscopic bariatric and metabolic treatments. Clin Endosc [Internet]. 2021;54:25\u201331. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33684282","DOI":"10.5946\/ce.2021.021"},{"key":"6379_CR4","doi-asserted-by":"crossref","unstructured":"Colquitt JL, Pickett K, Loveman E, Frampton GK. Surgery for weight loss in adults. Cochrane Database Syst Rev [Internet]. 2014;CD003641. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25105982","DOI":"10.1002\/14651858.CD003641.pub4"},{"key":"6379_CR5","doi-asserted-by":"crossref","unstructured":"Condello G, Chen C-Y. Minireview: current status of endoscopic duodenal mucosal resurfacing. Obes Res Clin Pract [Internet]. 2020;14:504\u20137. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32952067","DOI":"10.1016\/j.orcp.2020.09.001"},{"key":"6379_CR6","doi-asserted-by":"crossref","unstructured":"Cambi MPC, Baretta GAP, Magro DDO, Boguszewski CL, Ribeiro IB, Jirapinyo P, et al. Multidisciplinary approach for weight regain\u2014how to manage this challenging condition: an expert review. Obes Surg [Internet]. 2021;31:1290\u2013303. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33392999","DOI":"10.1007\/s11695-020-05164-1"},{"key":"6379_CR7","doi-asserted-by":"crossref","unstructured":"Nguyen NT, Masoomi H, Magno CP, Nguyen X-MT, Laugenour K, Lane J. Trends in use of bariatric surgery, 2003\u22122008. J Am Coll Surg [Internet]. 2011;213:261\u20136. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21624841","DOI":"10.1016\/j.jamcollsurg.2011.04.030"},{"key":"6379_CR8","unstructured":"de Moura EGH, Orso IRB, Martins BC, Lopes GS. Endoscopic therapeutic option for weight loss and control of type 2 diabetes: the duodenal-jejunal bypass liner. Surg Technol Int [Internet]. 2015;26:115\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26054998"},{"key":"6379_CR9","doi-asserted-by":"crossref","unstructured":"Tatarian T, Rona KA, Shin DH, Chen DG, Ducoin CG, Moore RL, et al. Evolving procedural options for the treatment of obesity. Curr Probl Surg [Internet]. 2020;57:100742. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011384020300125","DOI":"10.1016\/j.cpsurg.2020.100742"},{"key":"6379_CR10","doi-asserted-by":"crossref","unstructured":"ASGE Bariatric Endoscopy Task Force and ASGE Technology Committee, Abu Dayyeh BK, Kumar N, Edmundowicz SA, Jonnalagadda S, Larsen M, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc [Internet]. 2015;82:425\u201338.e5. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26232362","DOI":"10.1016\/j.gie.2015.03.1964"},{"key":"6379_CR11","unstructured":"ASGE\/ASMBS Task Force on Endoscopic Bariatric Therapy. A pathway to endoscopic bariatric therapies. Surg Obes Relat Dis [Internet]. 7:672\u201382. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22082971"},{"key":"6379_CR12","doi-asserted-by":"crossref","unstructured":"Dindo D, Demartines N, Clavien P-A. Classification of surgical complications. Ann Surg [Internet]. 2004;240:205\u201313. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15273542","DOI":"10.1097\/01.sla.0000133083.54934.ae"},{"key":"6379_CR13","doi-asserted-by":"crossref","unstructured":"Nass KJ, Zwager LW, van der Vlugt M, Dekker E, Bossuyt PMM, et al. Novel classification for adverse events in GI endoscopy: the AGREE classification. Gastrointest Endosc [Internet]. 2022;95:1078\u201385. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/ 34890695.","DOI":"10.1016\/j.gie.2021.11.038"},{"key":"6379_CR14","doi-asserted-by":"crossref","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ [Internet]. 2019;366:l4898. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31462531","DOI":"10.1136\/bmj.l4898"},{"key":"6379_CR15","doi-asserted-by":"crossref","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ [Internet]. 2008;336:924\u20136. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18436948","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"6379_CR16","doi-asserted-by":"crossref","unstructured":"Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol [Internet]. 2005;5:13. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15840177","DOI":"10.1186\/1471-2288-5-13"},{"key":"6379_CR17","unstructured":"Ruban A, Miras AD, Glaysher MA, Goldstone AP, Prechtl CG, Johnson N, et al. Duodenal-jejunal bypass liner for the management of type 2 diabetes mellitus and obesity. Ann Surg [Internet]. 2022;275:440\u20137. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34647708"},{"key":"6379_CR18","doi-asserted-by":"crossref","unstructured":"Ruban A, Glaysher MA, Miras AD, Goldstone AP, Prechtl CG, Johnson N, et al. A duodenal sleeve bypass device added to intensive medical therapy for obesity with type 2 diabetes: a RCT. Effic Mech Eval [Internet]. 2020;7:1\u2013130. Available from: https:\/\/www.journalslibrary.nihr.ac.uk\/eme\/eme07060","DOI":"10.3310\/eme07060"},{"key":"6379_CR19","unstructured":"Gupta P Sen, Amiel SA, Drummond R, McGowan B, Ryder B. One year efficacy, safety and tolerability of duodenal exclusion using endobarrier as an adjunct to glucagon-like-peptide-1 (GLP-1) therapy: a randomised controlled trial [Internet]. Endocr. Soc. 98th Annu. Mtg. Boston; 2016. Report No.: 569. Available from: https:\/\/www.easd.org\/virtualmeeting\/home.html#!resources\/one-year-efficacy-safety-and-tolerability-of-duodenal-exclusion-using-endobarrier-as-an-adjunct-to-glucagon-like-peptide-1-glp-1-therapy-a-randomised-controlled-trial"},{"key":"6379_CR20","doi-asserted-by":"crossref","unstructured":"Gersin KS, Rothstein RI, Rosenthal RJ, Stefanidis D, Deal SE, Kuwada TS, et al. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates. Gastrointest Endosc [Internet]. 2010;71:976\u201382. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20304396","DOI":"10.1016\/j.gie.2009.11.051"},{"key":"6379_CR21","doi-asserted-by":"crossref","unstructured":"Rodriguez L, Reyes E, Fagalde P, Oltra MS, Saba J, Aylwin CG, et al. Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes. Diabetes Technol Ther [Internet]. 2009;11:725\u201332. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19905889","DOI":"10.1089\/dia.2009.0063"},{"key":"6379_CR22","doi-asserted-by":"crossref","unstructured":"Tarnoff M, Rodriguez L, Escalona A, Ramos A, Neto M, Alamo M, et al. Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery. Surg Endosc [Internet]. 2009;23:650\u20136. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19067075","DOI":"10.1007\/s00464-008-0125-4"},{"key":"6379_CR23","doi-asserted-by":"crossref","unstructured":"Caiazzo R, Branche J, Raverdy V, Czernichow S, Carette C, Robert M, et al. Efficacy and safety of the duodeno-jejunal bypass liner in patients with metabolic syndrome. Ann Surg [Internet]. 2020;272:696\u2013702. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32889869","DOI":"10.1097\/SLA.0000000000004339"},{"key":"6379_CR24","doi-asserted-by":"crossref","unstructured":"Koehestanie P, de Jonge C, Berends FJ, Janssen IM, Bouvy ND, Greve JWM. The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial. Ann Surg [Internet]. 2014;260:984\u201392. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25072436","DOI":"10.1097\/SLA.0000000000000794"},{"key":"6379_CR25","doi-asserted-by":"publisher","unstructured":"Benes M, Hucl T, Drastich P, Haluzik M, Spicak J. Duodeno-jejunal bypass liner for the treatment of diabetes mellitus in obese patients: completeness of duodenal blinding as the key factor for efficacy. 2019. Available from: http:\/\/www.thieme-connect.de\/DOI\/DOI?https:\/\/doi.org\/10.1055\/s-0039-1681326","DOI":"10.1055\/s-0039-1681326"},{"key":"6379_CR26","doi-asserted-by":"crossref","unstructured":"Glaysher MA, Ward J, Aldhwayan M, Ruban A, Prechtl CG, Fisk HL, et al. The effect of a duodenal-jejunal bypass liner on lipid profile and blood concentrations of long chain polyunsaturated fatty acids. Clin Nutr [Internet]. 2021;40:2343\u201354. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33131909","DOI":"10.1016\/j.clnu.2020.10.026"},{"key":"6379_CR27","doi-asserted-by":"crossref","unstructured":"Schouten R, Rijs CS, Bouvy ND, Hameeteman W, Koek GH, Janssen IMC, et al. A multicenter, randomized efficacy study of the endobarrier gastrointestinal liner for presurgical weight loss prior to bariatric surgery. Ann Surg [Internet]. 2010;251:236\u201343. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19858703","DOI":"10.1097\/SLA.0b013e3181bdfbff"},{"key":"6379_CR28","unstructured":"U.S. Food & Drugs Administration. Discussion paper: consideration of benefit-risk approaches for weight-loss devices. US Food Drugs Adm [Internet]. 2019; Available from: https:\/\/www.fda.gov\/media\/130422\/download"},{"key":"6379_CR29","doi-asserted-by":"crossref","unstructured":"Mechanick JI, Apovian C, Brethauer S, Garvey WT, Joffe AM, Kim J, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures \u2013 2019 update: cosponsored by American Association of Clinical Endocrinologists\/American College of Endocrinology,. Endocr Pract [Internet]. 2019;25:1\u201375. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31682518","DOI":"10.4158\/GL-2019-0406"},{"key":"6379_CR30","doi-asserted-by":"crossref","unstructured":"Roehlen N, Laubner K, Bettinger D, Schwacha H, Hilger H, Koenig C, et al. Duodenal-jejunal bypass liner (DJBL) improves cardiovascular risk biomarkers and predicted 4-year risk of major cv events in patients with type 2 diabetes and metabolic syndrome. Obes Surg [Internet]. 2020;30:1200\u201310. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31898040","DOI":"10.1007\/s11695-019-04324-2"},{"key":"6379_CR31","doi-asserted-by":"crossref","unstructured":"Tripolt NJ, Aberer F, Url J, H\u00f6genauer C, Schreiber F, Eherer A, et al. Impact of duodeno-jejunal bypass liner (EndoBarrierTM) implantation on insulin sensitivity in patients with type 2 diabetes mellitus (T2DM): a study protocol for a pilot trial. Diabetes Ther [Internet]. 2019;10:299\u2013309. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30539524","DOI":"10.1007\/s13300-018-0540-z"},{"key":"6379_CR32","doi-asserted-by":"crossref","unstructured":"Rohde U, Federspiel CA, Vilmann P, Langholz E, Friis SU, Krakauer M, et al. The impact of endobarrier gastrointestinal liner in obese patients with normal glucose tolerance and in patients with type 2 diabetes. Diabetes, Obes Metab [Internet]. 2017;19:189\u201399. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27696668","DOI":"10.1111\/dom.12800"},{"key":"6379_CR33","doi-asserted-by":"crossref","unstructured":"Betzel B, Homan J, Aarts EO, Janssen IMC, de Boer H, Wahab PJ, et al. Weight reduction and improvement in diabetes by the duodenal-jejunal bypass liner: a 198 patient cohort study. Surg Endosc [Internet]. 2017;31:2881\u201391. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27804045","DOI":"10.1007\/s00464-016-5299-6"},{"key":"6379_CR34","doi-asserted-by":"crossref","unstructured":"de Jonge C, Rensen SS, D\u2019Agnolo HMA, Bouvy ND, Buurman WA, Greve JWM. Six months of treatment with the endoscopic duodenal-jejunal bypass liner does not lead to decreased systemic inflammation in obese patients with type 2 diabetes. Obes Surg [Internet]. 2014;24:337\u201341. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24357127","DOI":"10.1007\/s11695-013-1154-1"},{"key":"6379_CR35","doi-asserted-by":"crossref","unstructured":"Vilarrasa N, de Gordejuela AGR, Casajoana A, Duran X, Toro S, Espinet E, et al. Endobarrier\u00ae in grade I obese patients with long-standing type 2 diabetes: role of gastrointestinal hormones in glucose metabolism. Obes Surg [Internet]. 2017;27:569\u201377. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27468906","DOI":"10.1007\/s11695-016-2311-0"},{"key":"6379_CR36","doi-asserted-by":"crossref","unstructured":"Stratmann B, Krepak Y, Schiffer E, Jarick I, Hauber M, Lee-Barkey Y, et al. Beneficial metabolic effects of duodenal jejunal bypass liner for the treatment of adipose patients with type 2 diabetes mellitus: analysis of responders and non-responders. Horm Metab Res [Internet]. 2016;48:630\u20137. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27589345","DOI":"10.1055\/s-0042-115175"},{"key":"6379_CR37","doi-asserted-by":"crossref","unstructured":"Koehestanie P, Dogan K, Berends F, Janssen I, Wahab P, Groenen M, et al. Duodenal-jejunal bypass liner implantation provokes rapid weight loss and improved glycemic control, accompanied by elevated fasting ghrelin levels. Endosc Int Open [Internet]. 2014;2:E21\u20137. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26134609","DOI":"10.1055\/s-0034-1365222"},{"key":"6379_CR38","doi-asserted-by":"crossref","unstructured":"de Jonge C, Rensen SS, Verdam FJ, Vincent RP, Bloom SR, Buurman WA, et al. Impact of duodenal-jejunal exclusion on satiety hormones. Obes Surg [Internet]. 2016;26:672\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26446491","DOI":"10.1007\/s11695-015-1889-y"},{"key":"6379_CR39","doi-asserted-by":"crossref","unstructured":"de Jonge C, Rensen SS, Verdam FJ, Vincent RP, Bloom SR, Buurman WA, et al. Endoscopic duodenal\u2013jejunal bypass liner rapidly improves type 2 diabetes. Obes Surg [Internet]. 2013;23:1354\u201360. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23526068","DOI":"10.1007\/s11695-013-0921-3"},{"key":"6379_CR40","doi-asserted-by":"crossref","unstructured":"Kav\u00e1lkov\u00e1 P, Mr\u00e1z M, Trachta P, Klou\u010dkov\u00e1 J, Cinkajzlov\u00e1 A, Lacinov\u00e1 Z, et al. Endocrine effects of duodenal\u2013jejunal exclusion in obese patients with type 2 diabetes mellitus. J Endocrinol [Internet]. 2016;231:11\u201322. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27474690","DOI":"10.1530\/JOE-16-0206"},{"key":"6379_CR41","doi-asserted-by":"crossref","unstructured":"de Moura EGH, Lopes GS, da Costa Martins B, Orso IRB, Coutinho AMN, de Oliveira SL, et al. Effects of duodenal-jejunal bypass liner (EndoBarrier\u00ae) on gastric emptying in obese and type 2 diabetic patients. Obes Surg [Internet]. 2015;25:1618\u201325. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25691349","DOI":"10.1007\/s11695-015-1594-x"},{"key":"6379_CR42","doi-asserted-by":"crossref","unstructured":"Jung SH, Yoon JH, Choi HS, Nam S-J, Kim KO, Kim DH, et al. Comparative efficacy of bariatric endoscopic procedures in the treatment of morbid obesity: a systematic review and network meta-analysis. Endoscopy [Internet]. 2020;52:940\u201354. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32325513","DOI":"10.1055\/a-1149-1862"},{"key":"6379_CR43","doi-asserted-by":"crossref","unstructured":"Rohde U, Hedb\u00e4ck N, Gluud LL, Vilsb\u00f8ll T, Knop FK. Effect of the EndoBarrier gastrointestinal liner on obesity and type 2 diabetes: a systematic review and meta-analysis. Diabetes, Obes Metab [Internet]. 2016;18:300\u20135. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26537317","DOI":"10.1111\/dom.12603"},{"key":"6379_CR44","doi-asserted-by":"crossref","unstructured":"Jirapinyo P, Haas A V, Thompson CC. Effect of the duodenal-jejunal bypass liner on glycemic control in patients with type 2 diabetes with obesity: a meta-analysis with secondary analysis on weight loss and hormonal changes. diabetes care [Internet]. 2018;41:1106\u201315. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29678867","DOI":"10.2337\/dc17-1985"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-022-06379-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-022-06379-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-022-06379-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T15:04:52Z","timestamp":1675177492000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-022-06379-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["6379"],"URL":"https:\/\/doi.org\/10.1007\/s11695-022-06379-0","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"9 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Research Ethics Committee of the University of S\u00e3o Paulo School of Medicine Hospital das Cl\u00ednicas. For this type of study, formal consent is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed written consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent Statement"}},{"value":"Dr. Diogo Turiani Hourneaux De Moura is supported by BariaTek\u2014Advisory Board Member (Consulting fees). Dr. Sergio A. Sanch\u00e9z-Luna is a recipient of the 2021 American Society for Gastrointestinal Endoscopy (ASGE) Endoscopic Training Award by the ASGE and Fujifilm. This was not relevant to this study. Dr. Eduardo Guimaraes Hourneaux De Moura is supported by Olympus\u2014Consultant (Consulting fees), Boston Scientific\u2014Consultant (Consulting fees). They were not relevant to this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}